Prophylactic and therapeutic effects of (6)-shogaol on alveolar bone loss in experimental periodontitis.

IF 0.9 Q3 DENTISTRY, ORAL SURGERY & MEDICINE
Didem Bezirci, Meltem Karsiyaka Hendek, Gonen Ozcan, Oguz Kul, Tugce Anteplioglu, Ebru Olgun
{"title":"Prophylactic and therapeutic effects of (6)-shogaol on alveolar bone loss in experimental periodontitis.","authors":"Didem Bezirci, Meltem Karsiyaka Hendek, Gonen Ozcan, Oguz Kul, Tugce Anteplioglu, Ebru Olgun","doi":"10.26650/eor.20241248958","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>(6)-Shogaol is the most prevalent bioactive compound in ginger. The aim of this study was to examine both the prophylactic and therapeutic effects of (6)-shogaol in an experimental periodontitis model.</p><p><strong>Materials and methods: </strong>Thirty-five male Wistar albino rats were divided into four groups. In the healthy group (n=5), no intervention was undertaken. In the periodontitis group (n=10), periodontitis was induced by ligature placement for 14 days. In the prophylaxis group (n=10), periodontitis was induced with ligature placement for 14 days, and during this time, 20 mg/kg/day of (6)-shogaol was administered via oral gavage. In the therapeutic group (n=10), periodontitis was induced with ligature placement for 14 days, and following the removal of the ligature, 20 mg/kg/day of (6)-shogaol was administered via oral gavage for 14 days. Alveolar bone loss was histometrically measured, and malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GP), nuclear factor kappa B (NF-κB), receptor activator of nuclear factor kappa B ligand (RANKL), and osteoprotegerin (OPG) were immunohistochemically analyzed.</p><p><strong>Results: </strong>Alveolar bone loss was significantly lower in the healthy group than in the remaining groups, as well as in the therapeutic group than in the periodontitis group (p<0.001). RANKL/OPG was significantly higher in the periodontitis group compared to the remaining groups and in the prophylaxis group compared to the therapeutic group (p<0.001). MDA was significantly lower in the healthy group than in the remaining groups (p<0.001). SOD was significantly lower in the periodontitis group than in the prophylaxis and therapeutic groups (p=0.039 and p=0.042, respectively). GP was significantly lower in the healthy group than in the prophylaxis and therapeutic groups (p=0.031 and p=0.002, respectively).</p><p><strong>Conclusion: </strong>The administration of (6)-shogaol modulated the RANKL/OPG balance and antioxidant status in rats with ligature-induced periodontitis.</p>","PeriodicalId":41993,"journal":{"name":"European Oral Research","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927708/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Oral Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26650/eor.20241248958","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: (6)-Shogaol is the most prevalent bioactive compound in ginger. The aim of this study was to examine both the prophylactic and therapeutic effects of (6)-shogaol in an experimental periodontitis model.

Materials and methods: Thirty-five male Wistar albino rats were divided into four groups. In the healthy group (n=5), no intervention was undertaken. In the periodontitis group (n=10), periodontitis was induced by ligature placement for 14 days. In the prophylaxis group (n=10), periodontitis was induced with ligature placement for 14 days, and during this time, 20 mg/kg/day of (6)-shogaol was administered via oral gavage. In the therapeutic group (n=10), periodontitis was induced with ligature placement for 14 days, and following the removal of the ligature, 20 mg/kg/day of (6)-shogaol was administered via oral gavage for 14 days. Alveolar bone loss was histometrically measured, and malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GP), nuclear factor kappa B (NF-κB), receptor activator of nuclear factor kappa B ligand (RANKL), and osteoprotegerin (OPG) were immunohistochemically analyzed.

Results: Alveolar bone loss was significantly lower in the healthy group than in the remaining groups, as well as in the therapeutic group than in the periodontitis group (p<0.001). RANKL/OPG was significantly higher in the periodontitis group compared to the remaining groups and in the prophylaxis group compared to the therapeutic group (p<0.001). MDA was significantly lower in the healthy group than in the remaining groups (p<0.001). SOD was significantly lower in the periodontitis group than in the prophylaxis and therapeutic groups (p=0.039 and p=0.042, respectively). GP was significantly lower in the healthy group than in the prophylaxis and therapeutic groups (p=0.031 and p=0.002, respectively).

Conclusion: The administration of (6)-shogaol modulated the RANKL/OPG balance and antioxidant status in rats with ligature-induced periodontitis.

(6)-shogaol 对实验性牙周炎牙槽骨流失的预防和治疗作用。
目的:(6)-肖高醇是生姜中最常见的生物活性化合物。本研究旨在考察 (6)-Shogaol 在实验性牙周炎模型中的预防和治疗作用:35 只雄性 Wistar 白化大鼠分为四组。健康组(5 只)不采取任何干预措施。在牙周炎组(10 只),通过结扎诱发牙周炎,持续 14 天。在预防组(10 人)中,通过结扎诱发牙周炎 14 天,在此期间,通过口腔灌胃给药 20 毫克/千克/天的 (6)- 肖高醇。在治疗组(n=10)中,结扎诱发牙周炎 14 天,拆除结扎后,通过口服给药的方式每天服用 20 毫克/千克的(6)-shogaol,连续服用 14 天。对牙槽骨损失进行组织测量,并对丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GP)、核因子卡巴B(NF-κB)、核因子卡巴B配体受体激活剂(RANKL)和骨保护素(OPG)进行免疫组化分析:结果:健康组的牙槽骨损失明显低于其余各组,治疗组的牙槽骨损失也明显低于牙周炎组(p结论:结扎诱导的牙周炎大鼠服用(6)-肖高醇可调节RANKL/OPG平衡和抗氧化状态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Oral Research
European Oral Research DENTISTRY, ORAL SURGERY & MEDICINE-
CiteScore
1.60
自引率
0.00%
发文量
23
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信